KDA Group - Open Health | Smart Health
  • Home
  • Corporate Information
  • Leadership Team
  • Financial Information
  • Media
  • Contact
  • Français
Select Page

KDA Group announces interim Chief Financial Officer, Finance Director and appointment at its subsidiary Pharmapar Inc.

by kdamaster | Mar 9, 2018 | Sedar

Thetford Mines, March 9, 2018 – KDA Group Inc. (TSXV: KDA) (“KDA Group” or the “Corporation”) announced today that it has accepted the resignation of its Chief Financial Officer, Mr. Bruno Dumais, effective immediately. Mr. Dumais is leaving the Corporation to pursue...

Recent Posts

  • KDA Group completes previously announced sales of a majority stake in Pharmapar
  • KDA Group signed a share purchase agreement with Strides for the sales of majority stake in Pharmapar
  • KDA Group has signed a letter of intent with Strides for the sales of a majority stake in Pharmapar
  • KDA Group not to proceed with the project to distribute the ZRx Prescriber in the United States
  • KDA Group becomes the majority shareholder of CanNorth Medic Inc., a company in the cannabis field for medical purposes

Recent Comments

    Archives

    • February 2019
    • December 2018
    • August 2018
    • July 2018
    • June 2018
    • March 2018
    • January 2018
    • December 2017
    • June 2017
    • January 2017
    • October 2016
    • August 2016
    • July 2016
    • January 2016
    • December 2015
    • September 2015
    • June 2015
    • January 2015

    Categories

    • Market Wired
    • Non classé
    • Sedar
    • TSX

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org